PE20140036A1 - Metodos y composiciones para tratar diarrea asociada con vih - Google Patents

Metodos y composiciones para tratar diarrea asociada con vih

Info

Publication number
PE20140036A1
PE20140036A1 PE2013000926A PE2013000926A PE20140036A1 PE 20140036 A1 PE20140036 A1 PE 20140036A1 PE 2013000926 A PE2013000926 A PE 2013000926A PE 2013000926 A PE2013000926 A PE 2013000926A PE 20140036 A1 PE20140036 A1 PE 20140036A1
Authority
PE
Peru
Prior art keywords
hiv
diarrhea
compositions
methods
treat hiv
Prior art date
Application number
PE2013000926A
Other languages
English (en)
Inventor
William Forbes
Enoch Bortey
Steven King
Pravin Chaturvedi
Original Assignee
Napo Pharmaceuticals Inc
Salix Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45994461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20140036(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Napo Pharmaceuticals Inc, Salix Pharmaceuticals Ltd filed Critical Napo Pharmaceuticals Inc
Publication of PE20140036A1 publication Critical patent/PE20140036A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

SE REFIERE A UN METODO PARA TRATAR DIARREA ASOCIADA CON VIH O DIARREA ASOCIADA CON TERAPIA ANTIRETROVIRAL ALTAMENTE ACTIVA (HAART) EN UN SUJETO VIH POSITIVO QUE COMPRENDE ADMINISTRAR DE 250MG A 1000MG POR DIA DE UN INHIBIDOR DE TRANSPORTE DE IONES DE CLORURO TAL COMO CROFELEMER DURANTE UN PERIODO DE 3 DIAS A 6 MESES. TAMBIEN SE REFIERE A UN METODO PARA MEJORAR LA CONSISTENCIA DE HECES, REDUCIR EL NUMERO DE MOVIMIENTOS INTESTINALES POR DIA Y ALIVIAR LA DIARREA ACUOSA EN UN SUJETO VIH POSITIVO MEDIANTE LA ADMINISTRACION DE CROFELEMER
PE2013000926A 2010-10-31 2011-10-31 Metodos y composiciones para tratar diarrea asociada con vih PE20140036A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40862210P 2010-10-31 2010-10-31
US40933510P 2010-11-02 2010-11-02
US41624910P 2010-11-22 2010-11-22
US201161434379P 2011-01-19 2011-01-19

Publications (1)

Publication Number Publication Date
PE20140036A1 true PE20140036A1 (es) 2014-01-31

Family

ID=45994461

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2013000926A PE20140036A1 (es) 2010-10-31 2011-10-31 Metodos y composiciones para tratar diarrea asociada con vih

Country Status (19)

Country Link
US (4) US8962680B2 (es)
EP (1) EP2632550B1 (es)
JP (2) JP6063385B2 (es)
CN (2) CN103370101A (es)
AU (1) AU2011320155B2 (es)
BR (1) BR112013010774A2 (es)
CA (1) CA2816416C (es)
DK (1) DK2632550T3 (es)
EC (1) ECSP13012650A (es)
ES (1) ES2635435T3 (es)
HK (1) HK1249036A1 (es)
HU (1) HUE035393T2 (es)
MX (1) MX348184B (es)
PE (1) PE20140036A1 (es)
PL (1) PL2632550T3 (es)
PT (1) PT2632550T (es)
RU (1) RU2597746C2 (es)
WO (1) WO2012058664A1 (es)
ZA (1) ZA201303136B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090009292A (ko) 2006-05-01 2009-01-22 나포 팔마큐티칼스 인코퍼레이션 변비 우세형 과민성 대장 증후군을 치료하는 방법
PT2529626T (pt) * 2006-05-01 2018-02-27 Napo Pharmaceuticals Inc Composições e métodos para tratamento ou prevenção do cancro do cólon
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
RU2597746C2 (ru) 2010-10-31 2016-09-20 Напо Фармасьютиклз, Инк. Способы и композиции для лечения вич-ассоциированной диареи
JP2016505561A (ja) * 2012-12-07 2016-02-25 サリックス ファーマスーティカルズ，リミテッド Ｈｉｖ関連下痢を治療する方法および組成物
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
JOP20190275A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج اضطراب إسهال خِلقي
JOP20190276A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
US11216742B2 (en) 2019-03-04 2022-01-04 Iocurrents, Inc. Data compression and communication using machine learning
EP4168027A4 (en) * 2020-06-19 2024-04-03 Napo Pharmaceuticals Inc METHODS AND COMPOSITIONS FOR TREATING CHEMOTHERAPY-INDUCED DIARRHEA
WO2022115481A1 (en) * 2020-11-24 2022-06-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating post-acute infection gastrointestinal disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
AU4988197A (en) 1996-10-16 1998-05-11 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compo sitions
WO2000047062A2 (en) * 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
US20040071793A1 (en) 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
WO2005074575A2 (en) * 2004-01-30 2005-08-18 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
CA2667449A1 (en) * 2005-06-22 2007-01-04 University Of Massachusetts Hiv-1 protease inhibitors, and methods of making and using them
JP2009524585A (ja) 2005-12-15 2009-07-02 バイエル・ヘルスケア・アクチェンゲゼルシャフト ウイルス感染を処置するためのジアリールウレア
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
PT2529626T (pt) * 2006-05-01 2018-02-27 Napo Pharmaceuticals Inc Composições e métodos para tratamento ou prevenção do cancro do cólon
KR20090009292A (ko) 2006-05-01 2009-01-22 나포 팔마큐티칼스 인코퍼레이션 변비 우세형 과민성 대장 증후군을 치료하는 방법
US20100092479A1 (en) 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
EA023814B1 (ru) 2009-08-26 2016-07-29 Гленмарк Фармасьютикалс Лтд. Способ получения полимерных композиций на основе проантоцианидина для фармацевтических форм
CA2777214A1 (en) 2009-10-06 2011-04-14 The Regents Of The University Of California Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
US20110087530A1 (en) 2009-10-09 2011-04-14 Visa U.S.A. Inc. Systems and Methods to Provide Loyalty Programs
RU2597746C2 (ru) 2010-10-31 2016-09-20 Напо Фармасьютиклз, Инк. Способы и композиции для лечения вич-ассоциированной диареи
WO2012101008A1 (en) 2011-01-27 2012-08-02 Glenmark Pharmaceuticals Limited Process for the production of proanthocyanidin polymeric composition
MY197454A (en) 2011-12-22 2023-06-19 Napo Pharmaceuticals Inc Non-enteric pharmaceutical composition comprising crofelemer
JP2016505561A (ja) 2012-12-07 2016-02-25 サリックス ファーマスーティカルズ，リミテッド Ｈｉｖ関連下痢を治療する方法および組成物

Also Published As

Publication number Publication date
EP2632550B1 (en) 2017-05-03
US20150190367A1 (en) 2015-07-09
JP6310971B2 (ja) 2018-04-11
CN103370101A (zh) 2013-10-23
AU2011320155B2 (en) 2016-02-25
US9585868B2 (en) 2017-03-07
JP2017019806A (ja) 2017-01-26
ZA201303136B (en) 2016-01-27
HUE035393T2 (en) 2018-05-02
JP2013540826A (ja) 2013-11-07
ECSP13012650A (es) 2013-10-31
US20140294903A1 (en) 2014-10-02
EP2632550A4 (en) 2014-04-23
ES2635435T3 (es) 2017-10-03
US20120107370A1 (en) 2012-05-03
US20120184605A1 (en) 2012-07-19
CN107595836A (zh) 2018-01-19
JP6063385B2 (ja) 2017-01-18
MX348184B (es) 2017-06-02
PT2632550T (pt) 2017-08-02
RU2597746C2 (ru) 2016-09-20
MX2013004873A (es) 2013-08-21
PL2632550T3 (pl) 2017-10-31
US8962680B2 (en) 2015-02-24
CA2816416A1 (en) 2012-05-03
EP2632550A1 (en) 2013-09-04
CA2816416C (en) 2020-02-11
BR112013010774A2 (pt) 2017-03-21
WO2012058664A1 (en) 2012-05-03
DK2632550T3 (en) 2017-08-07
AU2011320155A1 (en) 2013-05-09
HK1249036A1 (zh) 2018-10-26
RU2013123794A (ru) 2014-12-10

Similar Documents

Publication Publication Date Title
PE20140036A1 (es) Metodos y composiciones para tratar diarrea asociada con vih
CL2021001292A1 (es) Terapia de combinación que incluye un inhibidor de krasg12c y uno o más agentes farmacéuticamente activos adicionales para el tratamiento de cánceres
CO2017001493A2 (es) Kits que comprenden inhibidores tigit y agentes anticáncer
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
MX2020004467A (es) Metodos para el tratamiento o la prevencion del asma mediante la administracion de antagonista de il-4r.
MX2015016100A (es) Inhibidores de criopirina para prevenir y tratar la inflamacion.
BR112018075736A2 (pt) composto de amida alfa e beta insaturado derivado de benzotriazol usado como inibidor de tgf-betar1
CL2020000220A1 (es) Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial.
BR112015019641A2 (pt) sistemas de entrega de endoprótese com a implantação adicional
CR20160433A (es) Nuevos compuestos
CL2019001996A1 (es) Usos terapéuticos de un polvo de insectos.
MX2021013354A (es) Metodos para tratar y/o prevenir queratosis actinica.
PH12015502679A1 (en) Methods of treatment and compositions with xanthine oxidase inhibitors
CL2010001594A1 (es) Uso de nifurtimox para preparar un medicamento útil en el tratamiento de enfermedades causadas por trichomonadida.
PH12019501820A1 (en) Pharmaceutical compositions for combination therapy
BR112017002449A2 (pt) tratamento de sintomas associados com terapia de privação androgênica
CL2020000221A1 (es) Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial.
CO6640306A2 (es) Combinación de inhibidores de xantina oxidasa y antagonistas del receptor de angiotensina ii y su uso
EA201990041A1 (ru) Композиции, содержащие тимолол, и их применение при лечении розацеа при местном применении
CO2020010047A2 (es) Métodos de terapia de testosterona
MY174065A (en) Methods and compositions for treating hiv-associated diarrhea
BR112018017167A2 (pt) titulação de cebranopadol
UA109159C2 (uk) Способи і композиції для лікування віл-асоційованої діареї
UA105323U (uk) Спосіб лікування курей, хворих на змішану нематодозно-цестодозну інвазію
UA109763C2 (ru) Способ лечения паховых и пахово-мошоночных грыж у новорожденных и мальчиков младшей возрастной группы

Legal Events

Date Code Title Description
FC Refusal